Avalo Therapeutics
AVTX
AVTX
61 hedge funds and large institutions have $180M invested in Avalo Therapeutics in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
44% less call options, than puts
Call options by funds: $84K | Put options by funds: $151K
Holders
61
Holding in Top 10
1
Calls
$84K
Puts
$151K
Top Buyers
| 1 | +$7.55M | |
| 2 | +$7.4M | |
| 3 | +$4.29M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.1M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
+$1.81M |
Top Sellers
| 1 | -$1.13M | |
| 2 | -$156K | |
| 3 | -$138K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$60.9K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$42K |